- Home
- BYD vs CORT Comparison
BYD vs CORT Comparison
Compare BYD & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BYD | CORT |
|---|---|---|
| Founded | 1973 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 8.6B |
| IPO Year | 1993 | N/A |
Fundamental Metrics
Financial Performance| Metric | BYD | CORT |
|---|---|---|
| Price | $87.42 | $85.18 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 6 |
| Target Price | $89.54 | ★ $130.20 |
| AVG Volume (30 Days) | 917.0K | ★ 965.7K |
| Earning Date | 02-05-2026 | 11-04-2025 |
| Dividend Yield | ★ 0.83% | N/A |
| EPS Growth | ★ 325.66 | N/A |
| EPS | ★ 22.22 | 0.87 |
| Revenue | ★ $4,070,839,000.00 | $741,172,000.00 |
| Revenue This Year | $2.59 | $23.79 |
| Revenue Next Year | N/A | $40.97 |
| P/E Ratio | ★ $3.89 | $95.90 |
| Revenue Growth | 5.91 | ★ 17.92 |
| 52 Week Low | $58.94 | $49.00 |
| 52 Week High | $88.49 | $117.33 |
Technical Indicators
Market Signals| Indicator | BYD | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 68.83 | 57.55 |
| Support Level | $84.87 | $78.07 |
| Resistance Level | $86.87 | $85.34 |
| Average True Range (ATR) | 1.44 | 3.48 |
| MACD | 0.52 | -0.22 |
| Stochastic Oscillator | 98.95 | 64.59 |
Price Performance
Historical ComparisonAbout BYD Boyd Gaming Corporation
Boyd Gaming Corp is a multi-jurisdictional gaming company. The company operates wholly-owned gaming entertainment properties (casino space, slot machines, table games, and hotel rooms) in Nevada, Illinois, Indiana, Iowa, Kansas, Louisiana, Mississippi, Missouri, Ohio, and Pennsylvania. Geographical regions separate its business segments: Las Vegas Locals, Downtown Las Vegas, Midwest and South, and Online. Midwest and South hold the key number of entertainment properties, and it generate the majority of sales for the company.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.